Pfizer will pay $60 million to settle allegations that one of its subsidiaries incentivized healthcare providers to prescribe ...

The company's revenue from operations dipped 0.4% to ₹538 crore as against ₹540 crore in the corresponding period of the preceding fiscal. At the operating level, EBITDA fell ...

Drug firm Pfizer on Friday said its net profit declined by 2 per cent to Rs 128 crore for the third quarter ended December 31, 2024.

The former President of Pfizer Global Manufacturing gifted $50 million to his former school, Northfield Mount Hermon.

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer (PFE – Research Report) yesterday and set a price target of $32.00. The ...

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from ...

Pfizer Inc. (NYSE:PFE), one of the world's largest pharmaceutical companies with a market capitalization of $151.25 billion, finds itself at a critical juncture as it navigates the post-pandemic ...

Following a tough opening salvo from Starboard Value last fall, Pfizer is getting a chance to catch its breath in the ...

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Over the years, the U.S. Department of Justice (DOJ) has taken a host of drugmakers to task over alleged kickback payments ...

The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.